Hypokalemia News and Research

RSS
Liquorice tea linked to hypertensive emergency – a case report

Liquorice tea linked to hypertensive emergency – a case report

Nexus announces availability of Arsenic Trioxide Injection in the US

Nexus announces availability of Arsenic Trioxide Injection in the US

FDA approves new treatment for people with hairy cell leukemia

FDA approves new treatment for people with hairy cell leukemia

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

FDA approves potassium chloride oral solution as first generic drug to receive CGT designation

FDA approves potassium chloride oral solution as first generic drug to receive CGT designation

Celgene to share new and updated data around novel hematological therapies

Celgene to share new and updated data around novel hematological therapies

Researchers reveal mechanisms of periodic paralysis in people with rare genetic disorder

Researchers reveal mechanisms of periodic paralysis in people with rare genetic disorder

FDA approves new radioactive drug for treatment of rare digestive tract cancers

FDA approves new radioactive drug for treatment of rare digestive tract cancers

ACADIA Pharmaceuticals announces results from Phase II study of antipsychotic in Alzheimer's disease psychosis

ACADIA Pharmaceuticals announces results from Phase II study of antipsychotic in Alzheimer's disease psychosis

Infantile spasms and multiple sclerosis relapse data presented at AAN

Infantile spasms and multiple sclerosis relapse data presented at AAN

BCL-2 inhibitor shows promise in AML patients

BCL-2 inhibitor shows promise in AML patients

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Bayer-new phase 3 liver cancer data

Bayer-new phase 3 liver cancer data

Eisai's Halaven receives FDA approval for treatment of patients with metastatic liposarcoma

Eisai's Halaven receives FDA approval for treatment of patients with metastatic liposarcoma

Lilly receives FDA approval for Humulin R U-500 KwikPen

Lilly receives FDA approval for Humulin R U-500 KwikPen

VistaPharm announces launch of Potassium Chloride Solution

VistaPharm announces launch of Potassium Chloride Solution

Perrigo receives FDA approval for generic version of KlorCon extended-release tablets

Perrigo receives FDA approval for generic version of KlorCon extended-release tablets

FDA grants accelerated approval to Praxbind (idarucizumab)

FDA grants accelerated approval to Praxbind (idarucizumab)

Boehringer Ingelheim announces FDA approval of Praxbind (idarucizumab)

Boehringer Ingelheim announces FDA approval of Praxbind (idarucizumab)